- Friday 1st of October 2021
Are Cenforce LD Tablets Used For Pulmonary Hypertension?
Cenforce LD tablets are mainly prescribed to treat Erectile Dysfunction. The medication contains Sildenafil, which works by relaxing blood vessels and increasing blood flow. In the case of erectile dysfunction, this improved circulation helps a man achieve and maintain an erection during sexual stimulation.
Although sildenafil is also used to treat Pulmonary Hypertension, Cenforce LD tablets are generally not prescribed for this condition. The treatment of pulmonary hypertension usually requires a different formulation and dosage specifically designed for that purpose. For example, sildenafil used for pulmonary hypertension is commonly marketed under brand names like Revatio, which is produced in doses and schedules appropriate for managing lung-related blood pressure.
The difference lies mainly in dosage, medical supervision, and treatment goals. Pulmonary hypertension treatment often involves lower doses taken multiple times a day under strict medical monitoring, while Cenforce LD is intended for occasional use before sexual activity.
Because of these differences, patients should not use Cenforce LD to self-treat pulmonary hypertension. Using the wrong dosage or formulation could lead to ineffective treatment or unwanted side effects such as dizziness, headaches, or dangerous drops in blood pressure.
Anyone diagnosed with pulmonary hypertension should consult a healthcare professional to receive the correct medication and dosage tailored to their condition.
Latest News
- Friday 1st of October 2021
“BIZ 2021” Entrepreneurial Day competition
- Friday 1st of October 2021
Workshop on modern assessment and the Use of Zoom Software in Learner-Centered Classroom (Academic staff)
- Friday 19th of March 2021
“Let’s Plant Trees for a Better Environment 2021”
- Friday 19th of March 2021
Biz 2020 – UWU Entrepreneurs’ Day
- Friday 19th of March 2021
Faculty of Management signs MoU with the Sri Lanka Institute of Marketing
- Friday 19th of March 2021
0 Replies:
Leave a Reply